[Clinical and pathophysiological aspects of thromboembolic phenomena in cancer].
Sheran
A
A
Naschitz
J E
JE
Yeshurun
D
D
D000970:Antineoplastic Agents / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000503:physiopathology; D013923:Thromboembolism / Q000209:etiology* / Q000503:physiopathology
D000970:Antineoplastic Agents